Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: S&P Capital IQ Factual Report
$150.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BASF SE And Dyadic International, Inc Enter Into Research And License Agreement


Wednesday, 15 May 2013 08:31am EDT 

BASF SE and Dyadic International, Inc announced that the two Companies have entered into a non-exclusive worldwide research and license agreement. Under the terms of the agreement, BASF will be able to use Dyadic's patented and proprietary C1 platform technology to develop, produce, distribute and sell industrial enzymes in certain fields for a variety of applications. BASF will fund research and development at Dyadic's research lab in The Netherlands. In addition to this funding, BASF has agreed to pay Dyadic a $6 million upfront license fee, and certain research and commercial milestone fees, as well as royalties upon commercialization. 

Company Quote

79.83
-1.23 -1.52%
11:35am EDT